ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      63,779.53
      1.42%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Lyell Immunopharma Inc (LYEL)

      7. Lyell Immunopharma Inc (LYEL) Financials

      LYEL Lyell Immunopharma Inc

      2.36
      -0.04 (-1.67%)
      May 03 2024 - Closed
      Delayed by 15 minutes

      Statistics

      Annual Quarterly
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Return on Assets (%) -46.569-27.935-24.583-17.736-27.807
      Return on Equity (%) 232.885101.315-78.53-20.773-31.532
      Return on Invested Capital (%) -60.697-47.725-37.448-28.59-37.563
      Operating Margin (%) -19692.085-2636.307-2349.474-216.239-180486.154
      Net Profit Margin (%) -19692.085-2636.307-2349.474-216.239-180486.154
      Book Value Per Share 36.49546.1433.833.3392.6
      Earnings Per Share -11.571-13.132-1.031-0.734-0.932
      Cash Per Share 8.6469.0181.210.4950.578
      Working Capital Per Share 37.40436.4972.3882.4612.065
      Operating Profit Per Share 0.0591.1040.0530.3580.012
      EBIT Per Share -11.571-13.132-1.031-0.734-0.932
      EBITDA Per Share -11.571-13.132-1.031-0.734-0.932
      Free Cash Flow Per Share -10.248-10.102-0.817-0.709-1.001

      Liquidity Ratios

      Year End December 30 2023 20192020202120222023
      Current Ratio 19.97112.5313.417.58916.069
      Quick Ratio 19.7812.4313.15417.28815.824
      Inventory Turnover (Days) N/A N/A N/A N/A N/A
      Shares Outstanding 11.18M15.57M242.74M249.57MN/A

      Key Stats and Ratios

      Year End December 30 2023 Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Shares Outstanding 242.74M245.42M247.11M249.24M249.57MN/AN/AN/A
      Return on Assets (%) N/A N/A N/A N/A N/A N/A N/A N/A
      Return on Equity (%) N/A N/A N/A N/A N/A N/A N/A N/A
      Return on Invested Capital (%) N/A N/A N/A N/A N/A N/A N/A N/A
      Operating Margin (%) N/A -12322.604 N/A N/A N/A -103013.846 N/A N/A
      Net Profit Margin (%) N/A -12322.604 N/A N/A N/A -103013.846 N/A N/A
      Sales Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Book Value Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Earnings Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Cash Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Working Capital Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Operating Profit Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      EBIT Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      EBITDA Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Free Cash Flow Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Current Ratio N/A 15.241 N/A N/A N/A 20.275 N/A N/A
      Quick Ratio N/A 14.953 N/A N/A N/A 19.897 N/A N/A
      Inventory Turnover (Days) N/A N/A N/A N/A N/A N/A N/A N/A

      Key Stats and Ratios

      Market Cap 599.67M
      Price to Earnings Ratio -2.56
      Price to Sales Ratio 205.22
      Price to Cash Ratio 4.12
      Price to Book Ratio 0.92
      Dividend Yield -

      Share Statistics

      Shares Outstanding 254.1M
      Average Volume (1 week) 590.26k
      Average Volume (1 Month) 954.14k
      52 Week Change 12.38%
      52 Week High 3.97
      52 Week Low 1.32
      More Ratios Coming Soon!

      Your Recent History

      NASDAQ
      LYEL
      Lyell Immunopharma
      Delayed Upgrade Clock